References
Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV, International Myeloma Working Group, eds. (2006) International uniform response criteria for multiple myeloma. Leukemia 20(9): 1467–1473
Klein U, Neben K, Hielscher T, Heiss C, Ho AD, Goldschmidt H. eds. (2011) Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment. Ann Hematol 90(4):429–439
McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson P G, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash, MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler, M, Rosenbaum, C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C, eds. (2012) Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med 366(19): 1770–1781
Levin SH, Mostofi FK, eds. (1970) Symptomatic plasmacytoma of the testis. Cancer 25(5):1193–1203
Hayes DW, Bennett WA, Heck FJ, eds. (1952) Extramedullary lesions in multiple myeloma; review of literature and pathologic studies. AMA Arch Pathol 53(3): 262–272
Anghel G, Petti N, Remotti D, Ruscio C, Blandino F, Majolino I, eds. (2002) Testicular plasmacytoma: report of a case and review of the literature. Am J Hematol 71:98–104
Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ, eds. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59: 2615–2622
Chen N, Lau H, Choudhury S, Wang X, Assaf M, Laskin, OL eds. (2010) Distribution of lenalidomide into semen of healthy men after multiple oral doses. J Clin Pharmacol 50:767–774
Rosenberg S, Shapur N, Gofrit O, Or R, eds. (2010) Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site? J Clin Oncol 28:e456–458
Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST eds. (2011) Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre-and post-rituximab. Ann Hematol 90(7): 809–818
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyao, K., Sakemura, R., Sakai, T. et al. Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report. Ann Hematol 93, 529–530 (2014). https://doi.org/10.1007/s00277-013-1835-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-013-1835-9